§ Federal grant opportunity · HT942526RCRPIDA
DoW Rare Cancers Idea Development Award
JoAnn Martin Grantor is accepting applications for DoW Rare Cancers Idea Development Award. The deadline is November 18, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- JoAnn Martin Grantor
- Application deadline
- November 18, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526RCRPIDA
Program overview
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should have high potential impact on rare cancers and the patient community.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from JoAnn Martin Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 18, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Orthopaedic, Applied Research Award
- DoW Rare Cancers Resource and Community Development Award
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- DoW Toxic Exposures Clinical Trial Award
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.